A Look into Food Allergy Diagnostics & Therapeutics Industry……Deep Analysis…..
The global food allergydiagnostics & therapeutics market
size is expected to reach USD 4.71
billion by 2026, according to a new report by Grand View Research, Inc.,
exhibiting a CAGR of 7.4%. The
market is expected to grow in the coming years owing to increasing incidence of
food allergies coupled with rising demand for products for management of these
conditions.
Multiple therapeutic regimens are being
followed across the globe in attempts to come up with a reliable treatment for
Covid-19. One line of treatment includes the use of hydroxychloroquine, while a
second treatment line focuses to use antiviral drugs used in the disease
management of HIV. Both these approaches have surged demand from advanced
antivirals and antimalarial drugs. This impacts the drug manufacturers as an
off label indication for these drug classes has to be worked upon. At the
moment, the WHO has not prescribed any of these approaches, neither they have
commented if one is better than the other. The report will account for Covid19
as a key market contributor.
There are more than 160 foods that can
lead to allergic reactions; however, only 8 most common allergens have been
identified by the FDA. These include eggs, milk, peanuts, soy, tree nuts,
wheat, shellfish, and fish. Some of the other allergens are corn, meat,
gelatin, seeds, spices, and fruits & vegetables. Based on Food Allergy
Research and Education (FARE) 2016 data, around 15 million people in the U.S.
have food allergy. Ingestion of any of the common allergens might lead to
anaphylaxis, a life-threatening allergic reaction, which might further result
in anaphylactic shock. Every year, around 2,000 hospitalizations, 30,000
emergency room visits, and 150 deaths due to anaphylaxis are recorded in the
U.S.
However, administering epinephrine
using an auto-injector during the early stage of anaphylaxis might help avoid
any serious complications. Treatment for food allergy costs around USD 25
billion annually in the U.S. Development of cost-effective in vitro diagnostic
tests for detection of allergy is expected to fuel the demand for diagnostic
products.
To Request Sample Copy of this report, click the link:
Further key findings from the study suggest:
·
Therapeutics segment dominated
the market in 2018 due to growing demand for antihistamines and epinephrine
auto-injector
·
Diagnostic segment includes
instruments, consumables, and services, wherein consumables accounted for the
largest share in 2018
·
The most common tests used to
diagnose food allergies are skin prick tests and blood tests
·
Peanut allergen source segment
is anticipated to register lucrative growth over the forecast period, owing to
novel product launches coupled with rising incidence of peanut allergies
worldwide.
·
Hospitals & clinics
dominated the food allergy diagnostics & therapeutics market in 2018 owing
to increase in number of hospitalizations due to severe allergic conditions
·
Europe held the largest share
in 2018 owing to increase in prevalence as well as awareness about various
symptoms of food allergic reactions in this region
·
Asia Pacific is anticipated to
exhibit significant growth during the forecast period due to rising disposable
income and incidence of shellfish allergy
·
Some of the key companies are
Allergy Therapeutics; Cambridge Allergy Ltd; Astellas Pharma, Inc.; Immunomic
Therapeutics, Inc.; bioMérieux SA; Omega Diagnostics Group PLC; and HYCOR
Biomedical
The
global food allergy diagnostics & therapeutics market size was valued at
USD 2.69 billion in 2018 and is expected to grow at a lucrative CAGR of 7.4%
over the forecast period. Rising prevalence of food allergy is anticipated to
drive the market. Symptoms associated with allergic response could range from
itchiness, swelling of tongue, or hives to low blood pressure, diarrhea, or
vomiting.
According
to World Allergy Organization, prevalence of food allergies is increasing
globally. Some of the most common allergens are eggs, milk, wheat, fish, and
tree nuts. Moreover, fish allergies are more prevalent in Asia than in western
countries. In addition, rising awareness about food allergy and high unmet
medical needs coupled with introduction of novel products in the market are
some of the other factors expected to contribute to the growth in the near
future.
According
to American Academy of Pediatrics, 5.6 million children in the U.S. have food
allergies, out of which around 40% have more than one allergy. It affects
around 6% to 8% of children below 3 years of age and around 3% of the adult
population. Increasing incidence of allergic conditions among both pediatric
and adult population drives the demand for cost-effective and advanced
therapeutics.
In
addition, technological advancements and increase in number of R&D
initiatives being undertaken for development of drugs with higher efficacy are
some of the drivers of this market. With introduction of epinephrine
auto-injector, treatment for peanut allergy or allergy to bee sting can be
easily provided. However, the cost of EpiPen is USD 630, which makes it
unaffordable for people in low-income countries.
Symptoms
of food allergy vary from person to person and might not result in the same
symptoms in different individuals. Food allergic reactions affect respiratory
tract, skin, cardiovascular system, and gastrointestinal tract. In order to
gain knowledge about the severity of the allergies, proper counselling about
the life-threatening risk factors of anaphylaxis should be undertaken.
Browse Press
Release of this report:
Grand View Research has segmented the food
allergy diagnostics & therapeutics market on the basis of product type,
allergen source, end use, and region:
Food Allergy Diagnostics &
Therapeutics Product Type Outlook (Revenue, USD Million, 2015 -
2026)
·
Diagnostic Products
o Instruments
o Consumables
o Services
o Tests Type
o In Vivo/Skin
o Skin Prick Test
o Patch Test
o In Vitro
·
Therapeutic Treatment Type
o Antihistamines
o Epinephrine Auto-injector
Food Allergy Diagnostics & Therapeutics Allergen
Source Outlook (Revenue, USD Million, 2015 - 2026)
·
Eggs
·
Milk
·
Peanuts
·
Fish
·
Shellfish
·
Tree Nuts
·
Wheat
·
Soy
·
Others
Food Allergy Diagnostics &
Therapeutics End-use Outlook (Revenue, USD Million, 2015 - 2026)
·
Academic Research Institutes
·
Hospitals & Clinics
·
Diagnostics Laboratories
About Grand View Research
Grand View Research, Inc. is a U.S.
based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, we offer market intelligence studies
ensuring relevant and fact-based research across a range of industries, from
technology to chemicals, materials and healthcare.
Comments
Post a Comment